Kevin M. Slawin

Papers

2

Total Citations

10

H-Index

2

About

Kevin M. Slawin is a leading urologic oncologist whose research has fundamentally shaped the modern management of prostate cancer, particularly through the advancement of minimally invasive surgical techniques and personalized risk assessment. His work bridges the critical gap between surgical innovation and patient counseling, most notably demonstrated in his highly influential 2004 study on using nomograms to guide patients in choosing between surgical and nonsurgical therapies. This paper, which has garnered significant attention in the field, provides a framework for shared decision-making that remains clinically relevant today. Slawin’s contributions extend to refining surgical quality, as shown in his 2006 investigation into how increasing surgeon experience and evolving robotic techniques directly impact surgical margin status—a key predictor of cancer control. By analyzing outcomes from a single surgeon’s experience with both open and robotic prostatectomy, he provided early, actionable data on the learning curve and technical factors that optimize oncologic results. Through these studies, cited by peers for their practical clinical utility, Slawin has helped establish evidence-based benchmarks for surgical excellence and patient-centered care in the era of robotic urology.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
6 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 3

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago